Clinical Trial Update: Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism [NA]

View source ↗

Summary

A clinical trial update describes a study to alert providers at hospital discharge to consider prescribing rivaroxaban to reduce venous thromboembolism; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Scott C. Woller, MD | Conditions: Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis | NA | Status: RECRUITING